These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23919444)

  • 21. Long-acting reversible contraception.
    Peck SA
    Nurs Womens Health; 2013 Oct; 17(5):431-5. PubMed ID: 24138662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unintended pregnancies and use, misuse and discontinuation of oral contraceptives.
    Rosenberg MJ; Waugh MS; Long S
    J Reprod Med; 1995 May; 40(5):355-60. PubMed ID: 7608875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acceptability and discontinuation of Depo-Provera, IUCD and combined pill in Kenya.
    Sekadde-Kigondu C; Mwathe EG; Ruminjo JK; Nichols D; Katz K; Jessencky K; Liku J
    East Afr Med J; 1996 Dec; 73(12):786-94. PubMed ID: 9103686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Duration of lactation and return of menstruation in lactating women using hormonal contraception and IUDs.
    Prema K
    Contracept Deliv Syst; 1982 Jan; 3(1):39-46. PubMed ID: 12264126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The contraceptive implant and the injectable: a comparison of costs.
    Westfall JM; Main DS
    Fam Plann Perspect; 1995; 27(1):34-6. PubMed ID: 7720851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormonal contraception.
    Baird DT; Glasier AF
    N Engl J Med; 1993 May; 328(21):1543-9. PubMed ID: 8479492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversible contraception for the woman over 35 years of age.
    Archer DF
    Curr Opin Obstet Gynecol; 1992 Dec; 4(6):891-6. PubMed ID: 1450355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-Effectiveness of Immediate Compared With Delayed Postpartum Etonogestrel Implant Insertion.
    Gariepy AM; Duffy JY; Xu X
    Obstet Gynecol; 2015 Jul; 126(1):47-55. PubMed ID: 26241255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cost-effectiveness of the levonorgestrel-releasing intrauterine system for the treatment of idiopathic heavy menstrual bleeding in the United States.
    Ganz ML; Shah D; Gidwani R; Filonenko A; Su W; Pocoski J; Law A
    Value Health; 2013; 16(2):325-33. PubMed ID: 23538185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extended regimens of the contraceptive vaginal ring versus hormonal oral contraceptives: effects on lipid metabolism.
    Guazzelli CA; Barreiros FA; Barbosa R; Torloni MR; Barbieri M
    Contraception; 2012 Apr; 85(4):389-93. PubMed ID: 22067754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Cost Effectiveness Model of Long-Acting Reversible Contraceptive Methods in the Brazilian National Health System.
    Farah D; de Moraes Andrade TR; Sansone D; Batista Castello Girão MJ; Fonseca MCM
    Am J Prev Med; 2022 Jan; 62(1):114-121. PubMed ID: 34922650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preventing unintended pregnancy among young women in Kenya: prospective cohort study to offer contraceptive implants.
    Hubacher D; Olawo A; Manduku C; Kiarie J; Chen PL
    Contraception; 2012 Nov; 86(5):511-7. PubMed ID: 22633247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Another view on Norplant: match method with users.
    Herndon N
    Netw Res Triangle Park N C; 1992 Oct; 13(2):24-6. PubMed ID: 12286081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormonal contraception and HIV acquisition risk: implications for individual users and public policies.
    Jain AK
    Contraception; 2012 Dec; 86(6):645-52. PubMed ID: 22541635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contraceptive development and better family planning.
    Segal SJ
    Bull N Y Acad Med; 1996; 73(1):92-104. PubMed ID: 8804742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pseudotumor cerebri syndrome with different types of hormonal contraceptives in women of child-bearing age.
    Etminan M; Khosrow-Khavar F; Sodhi M; Carleton B; Magee LA; Tremlett H; Kezouh A; Sheldon C
    Eur J Neurol; 2020 Dec; 27(12):2625-2629. PubMed ID: 32810878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of contraceptive failures associated with CYP3A4-inducing drug-drug interactions by route of hormonal contraceptive in an adverse event reporting system.
    Sunaga T; Cicali B; Schmidt S; Brown J
    Contraception; 2021 Apr; 103(4):222-224. PubMed ID: 33345974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contraception after unprotected sex.
    Blaney CL
    Netw Res Triangle Park N C; 1994 Dec; 15(2):4-8. PubMed ID: 12319047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch.
    Jick SS; Jick H
    Contraception; 2006 Oct; 74(4):290-2. PubMed ID: 16982227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.
    Sitruk-Ware RL; Menard J; Rad M; Burggraaf J; de Kam ML; Tokay BA; Sivin I; Kluft C
    Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.